Cafepharma Today

June 6 2025 - Novartis presses court for hasty decision in long-running Entresto patent feud with MSN
Novartis presses court for hasty decision in long-running Entresto patent feud with MSN
'Not a horse and pony show': At FDA cell and gene roundtable, officials look for ways to cut red tape
With ADCs on the rise, drugmakers embrace a new oncology pillar
Bayer trial combines two top drugs for kidney disease
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

What Amylin's Diabetes Treatment Complete Response Letter Means for Avanir
Seeking Alpha
Thursday, October 21, 2010 - 11:07am
tags:
Amylin, diabetes, Alkermes, Eli Lilly, Bydureon
GlaxoSmithKline profit down 3.5%, dividend raised
Marketwatch
Thursday, October 21, 2010 - 10:52am
tags:
GSK, earnings
Five Stocks Keeping Company With Viagra
Seeking Alpha
Thursday, October 21, 2010 - 10:51am
tags:
erectile dysfunction, Viagra, GSK, Eli Lilly, Merck, Pfizer, Bayer AG
Eli Lilly Net Rises 38% on Cost Cuts
TheStreet.com
Thursday, October 21, 2010 - 10:50am
tags:
Eli Lilly, earnings
Novartis net income up 10%, driven by new products
Marketwatch
Thursday, October 21, 2010 - 10:49am
tags:
Novartis, earnings
Actelion Sets $827 Million Share Repurchase as Takeover Speculation Swirls
Bloomberg
Thursday, October 21, 2010 - 10:48am
tags:
Actelion, share repurchase, M&A, earnings
Will Illumina Fall Short Next Quarter?
Motley Fool
Wednesday, October 20, 2010 - 9:39pm
tags:
Illumina
Lilly, MacroGenics Say Diabetes Treatment Misses Goal in Late-Stage Study
Bloomberg
Wednesday, October 20, 2010 - 9:38pm
tags:
diabetes, Macrogenics, Eli Lilly, teplizumab
J&J Makes Infectious Disease a Priority
WSJ Online
Wednesday, October 20, 2010 - 2:05pm
tags:
JNJ
VIVUS Shares Plunged: What You Need to Know
Motley Fool
Wednesday, October 20, 2010 - 1:54pm
tags:
Vivus, Qnexa
Genzyme's Clolar fails late-stage leukemia study
Yahoo/AP
Wednesday, October 20, 2010 - 12:16pm
tags:
Clolar, Genzyme, leukemia
Digging Into the Cash Flow at Biogen Idec
Motley Fool
Wednesday, October 20, 2010 - 11:20am
tags:
Biogen Idec
FDA Vows To Stand By Plavix And Prilosec Warnings
Pharmalot
Wednesday, October 20, 2010 - 11:15am
tags:
warnings, FDA, Plavix, Prilosec, Bristol-Myers Squibb, blood thinners, Sanofi
Avanir Addresses Safety Data From Pivotal STAR Trial
Seeking Alpha
Wednesday, October 20, 2010 - 11:13am
tags:
Avanir, STAR, ALS
How Accountable Care Organizations (ACOs) will affect Pharmaceutical Sales Representatives
Pharmareform
Wednesday, October 20, 2010 - 10:55am
tags:
Accountable Care Organizations, ACOs, drug reps
Six Reasons to Buy China Biologic Products
Seeking Alpha
Wednesday, October 20, 2010 - 10:53am
tags:
China Biologic, China
FDA Reaction to Transcept Insomnia Drug Trial Data Can Go Either Way
Seeking Alpha
Wednesday, October 20, 2010 - 10:53am
tags:
FDA, insomnia, Transcept, Intermezzo
Medicis: Genzyme filed patent infringement lawsuit
Yahoo/AP
Wednesday, October 20, 2010 - 10:51am
tags:
Genzyme, Medicis, patents, Restylane, Perlane
Amylin, Lilly, Alkermes Shares Slump as FDA Rejects Bydureon Diabetes Drug
Bloomberg
Wednesday, October 20, 2010 - 10:46am
tags:
Amylin, Eli Lilly, Alkermes, FDA, Bydureon, diabetes
Sanofi gets OK from U.S. authorities for Genzyme bid
Yahoo/Reuters
Wednesday, October 20, 2010 - 9:36am
tags:
Sanofi, Genzyme, M&A

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Cleaning Up the Medical Literature
In the Pipeline
Not One of Your Easy Crystals
In the Pipeline
The Continuing Crisis, Part XV: The Horrendous Trump Budget
In the Pipeline
Taurine Revisited
In the Pipeline
A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.